Learn about the latest developments in personalized medicine. Explore how advances in genomics, biomarker discovery, and precision treatments are transforming healthcare by tailoring therapies to individual patients.
Neurodegeneration specialist achieves over 50% enrollment in Phase 1b PRECISE-AD trial ProMIS Neurosciences announced significant progress in its 128-patient Phase 1b PRECISE-AD trial for Alzheimer’s
Key Takeaways: Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS remain critical unmet needs in medicine. Biotech innovations, from gene therapies to biomarkers, are paving the
Quick Summary Device: Embecta’s new disposable insulin patch pump with a 300-unit reservoir. FDA Clearance: Approved as a tubeless insulin delivery system for both Type
In a significant breakthrough, the FDA has approved two new drugs for the treatment of Niemann-Pick Disease Type C (NPC), a rare and debilitating genetic
Cambridge-based biotech company Shift Bioscience has raised $16 million in seed funding to drive forward its cellular reprogramming research aimed at combating age-related diseases. The
Personalized medicine, also known as precision medicine, is transforming the landscape of cancer treatment by tailoring therapies to each patient’s unique genetic makeup. This approach
Digital health has become a driving force in transforming patient care, enabling more efficient and accessible healthcare services. With advancements in telemedicine, wearable health technology,
As we move further into 2024, the medical technology industry continues to innovate at an incredible pace, bringing new devices that improve patient outcomes and
3D printing is revolutionizing the field of medicine, especially in surgical procedures and patient recovery. What once seemed futuristic is now a rapidly growing reality,
